Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement-156.79 K-47.72 K-134.26 K-48.95 K-20.65 K-27.61 K-10.72 KFlux de trésorerie liés aux activités de financement12.51 M12.78 M35.35 M4.06 M23.75 M19.08 M12.89 MFlux de trésorerie disponible-2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M-19.05 M
GeoVax Labs, Inc. - Common Stock
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.